Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema. 1983

J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka

Immunoglobulin G (IgG) fractions prepared from the serum of 18 patients with primary myxedema, 9 patients with goitrous Hashimoto's thyroiditis, and 14 normal controls were tested for their ability to alter TSH stimulation of cAMP production in cultured human thyroid cells and the binding of TSH to its receptor. When compared with the cAMP increase induced by 0.1 mU/ml bovine TSH in the presence of normal IgG, cAMP accumulation was significantly inhibited (P less than 0.005) by the addition of IgG from patients with primary myxedema. TSH-induced cAMP accumulation was not affected by IgG from patients with goitrous thyroiditis. IgG from patients with primary myxedema also inhibited the cAMP increase induced by thyroid-stimulating immunoglobulins, but not against the increase induced by prostaglandin E1. None of the IgG tested affected the basal level of cAMP. Two potent inhibitory IgG were strongly positive for TSH-binding inhibitor immunoglobulins. Excluding these, no significant correlation was found between the thyroid stimulation-blocking activity and the TSH-binding inhibitory activity. These data suggest the presence of at least two different types of antibodies in primary myxedema which block adenylate cyclase stimulation by TSH and might be responsible for thyroid dysfunction and atrophy.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009230 Myxedema A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips. Myxedemas
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067956 Adenylyl Cyclase Inhibitors Compounds that bind to and inhibit the action of ADENYLYL CYCLASES. Adenylate Cyclase Inhibitors,Cyclase Inhibitors, Adenylate,Cyclase Inhibitors, Adenylyl,Inhibitors, Adenylate Cyclase,Inhibitors, Adenylyl Cyclase
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
February 1972, Biochemical and biophysical research communications,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
February 1974, Science (New York, N.Y.),
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
August 1974, International journal of radiation biology and related studies in physics, chemistry, and medicine,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
March 1971, Biochemical and biophysical research communications,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
September 1981, The Journal of clinical endocrinology and metabolism,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
September 1980, The American journal of physiology,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
February 1977, Psychological medicine,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
January 1972, Comptes rendus des seances de la Societe de biologie et de ses filiales,
J Konishi, and Y Iida, and K Endo, and T Misaki, and Y Nohara, and N Matsuura, and T Mori, and K Torizuka
May 1979, Journal of reproduction and fertility,
Copied contents to your clipboard!